EDGAR Filing Documents for 9999999995-23-003325

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-23-003325

Accepted

2023-11-15 00:15:26

Documents

Effectiveness Date

2023-11-14

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	596
	Complete submission text file	9999999995-23-003325.txt		1913

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010

Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337

Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-275290 | Film No.: 231408936
SIC: 2836 Biological Products, (No Diagnostic Substances)